
Resof Total is a fixed-dose combination tablet containing Sofosbuvir (400mg) and Velpatasvir (100mg), used for the treatment of chronic Hepatitis C virus (HCV) infection.
| Generic Name | Sofosbuvir (400 mg) + Velpatasvir (100 mg) |
| Manufacturer | Dr. Reddy’s Laboratories Ltd |
| Packing | 28 Tablets |
| Prescribed For | Hepatitis C Virus |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




| Package | USD | GBP | AUD | NZD | PHP | KRW | RON | HKD | MYR | THB | AED |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 28 Tablets | $325 | £242 | A$456 | NZ$564 | ₱20,387 | ₩444,548 | lei 1,492 | HK$2,550 | RM1,311 | ฿10,806 | د.إ1,194 |
Sofosbuvir/Velpatasvir prices may vary between countries depending on the brand, dosage form, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement or medicine information.
Dr. Alka Yadav Jain is a qualified physician with professional experience in viral infection care and medication management. Her areas of interest include antiviral therapies, responsible prescribing, monitoring treatment response and supporting the safe use of medicines.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.